Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Antonio Costanzo, Carlo Giovanni Carrera et al.|Frontiers in Medicine|2023Cited by 55
Oxidative Stress and Alterations of Paraoxonases in Atopic DermatitisOriana Simonetti, Annamaria Offidani|Antioxidants|2021Cited by 49
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi et al.|Expert Opinion on Biological Therapy|2020Cited by 43
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registryAndrea Chiricozzi, Clara De Simone, Marco Galluzzo et al.|Allergy|2021Cited by 37
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience—IL PSO (Italian Landscape Psoriasis)Diego Orsini, Antonio Costanzo, Piergiorgio Malagoli et al.|Dermatology Practical & Conceptual|2024Cited by 34